Pregnant Women Clinical Trial
Official title:
Aplicación en la práctica clínica de la determinación Prenatal no Invasiva en el Genotipo RhD Fetal Durante el Primer Trimestre de la gestación en Gestantes RhD Negativas
Actually, our center is doing the prenatal determination of RhD fetal genotype in all RhD
negative pregnant women.
The investigator want to demonstrate that this is an useful and efficient method.
This is a retrospective observational study that pretend to demonstrate that the prenatal
determination of RhD fetal genotype is useful and efficient in our clinical practice.
I'm going to check the clinical history of all negative RhD pregnant women since January
2013 until December 2015.
I'll check if prenatal determination matches with postnatal RhD determination of newborn.
Usually, when a RhD negative woman is pregnant we administrate gammaglobulin in 28 gestation
weeks, after invasive procedures and after delivery if the baby is positive RhD.
Althought, the investigators know that the 40 percent of RhD negative pregnant have a
negative RhD baby.
This study will do posible to know how many gammaglobulins hasn't been necessary thanks to
prenatal determination.
This is an important thing because gammaglobulin is an humanoid product ( it isn't without
heatlth risks,...) and because is expensive.
For this reason, if the investigators do universal determination of RhD fetal genotype the
investigators can avoid the administration of humanoid product in pregnant women.
I want to demonstrate that this practice is very useful and efficient in our population.
;
Observational Model: Case-Only, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03955263 -
Malaria In Pregnancy in Central India
|
||
Not yet recruiting |
NCT04457947 -
Exploring Aromatherapy Intervention in Acute Care
|
||
Active, not recruiting |
NCT01397318 -
Effects of Modified TaiChi Exercise on Maternal Stress, Fatigue, Sleep Quality, Biomarkers, and Infant Gestational Age and Birthweight
|
N/A | |
Completed |
NCT00639145 -
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
|
||
Not yet recruiting |
NCT00931099 -
Fetal Outcome of Sleep Disordered Breathing During Pregnancy
|
N/A | |
Recruiting |
NCT00751569 -
microRNA Profile in Umbilical Cord Blood NK Cells
|
N/A | |
Completed |
NCT06111716 -
Mindfulness in Childbirth Preparation Education Process
|
N/A | |
Completed |
NCT05729191 -
Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women
|
||
Completed |
NCT01687634 -
Home Visiting for Low Income, Pregnant Women
|
N/A | |
Recruiting |
NCT05446571 -
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
|
Phase 3 | |
Not yet recruiting |
NCT03651934 -
Verification of Correlation Between Genetic Testing of Nutritional Metabolism and Clinical Biochemical Indicators
|
N/A | |
Active, not recruiting |
NCT06422130 -
Ningbo Maternity-Child Linked Database Study
|
||
Completed |
NCT02904473 -
Goals for Reaching Optimum Wellness (GROWell)
|
N/A | |
Completed |
NCT03538106 -
Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
|
||
Recruiting |
NCT01246765 -
National Pregnancy Registry for Psychiatric Medications
|
||
Completed |
NCT00553228 -
Pertussis Maternal Immunization Study
|
Phase 2/Phase 3 | |
Recruiting |
NCT05916534 -
We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare
|
N/A | |
Completed |
NCT04264910 -
CALM Pregnancy: Feasibility of Calm for Pregnant Women
|
N/A | |
Completed |
NCT04494581 -
GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
|
||
Recruiting |
NCT05349279 -
Qatar PREgnancy Covid-19 OUtcome Study
|